Part 1 of 3 in our article series: Understanding Omnichannel Pharma Marketing
In recent years, Omnichannel Pharma Marketing (OCM) has emerged as a pivotal development in the pharmaceutical market. In this article series, we aim to provide comprehensive insights into OCM, covering the following key aspects:
In our previous article, „What is Omnichannel Pharma Marketing?“, we discussed the customer journey as the foundation of OCM (Omnichannel Pharma Marketing) with the primary goal of connecting marketing and sales channels in ways that:
1. Address the specific needs of the target audience.
2. Deliver a consistent brand message across all channels and activities.
3. Engage doctors in their current decision-making phase.
In this article, we will delve deeper into understanding the mechanics behind the customer journey in OCM by examining its three critical entities:
1. Entity of the Customer Journey: Segmentation
At the core of the omnichannel approach is customer-centricity – aligning marketing and sales activities with the unique needs of the target audience. However, the needs of doctors within the target group can vary significantly, making a "one size fits all" approach inadequate.
To create an appropriate customer journey, the target group is segmented based on basic characteristics (explained in more detail in Part 3: Data Management in Omnichannel Pharmaceutical Marketing). By gathering data, physician cohorts with similar needs are formed, and a suitable customer journey is developed for each group. This approach strikes a balance between catering to different physicians' needs while efficiently utilizing resources. During the initial contact phases, it is beneficial to use specific content and sequences for several physicians simultaneously since a fully personalized approach might be impractical and costly at this stage.
2. Entity of the Customer Journey: Decision Phases
A physician's decision-making phase on the path to a prescription or a change of therapy is the second instance of the customer journey. Different phases influence the most relevant needs, topics, and channels for physicians at any given time. As a result the customer journey can be roughly divided into the following four phases:
- Awareness: The first phase primarily focuses on creating awareness among the target group, whether it involves building brand awareness for a new product or drawing attention to a particular disease and its treatment options. It's crucial to understand the number of contact points required to penetrate the target audience's awareness. Experts across industries estimate that around 15-20 contact points¹ are needed before a brand becomes actively perceived by customers – a figure that has increased significantly with digitization over the past decade. However, the emphasis is not solely on the quantity of touchpoints but more importantly on their quality. That's why OCM places its focus on two aspects: First, coordinating various touchpoints to deliver a consistent brand message, and second, tailoring measures to address the specific needs of the target group, ensuring their relevance. To effectively reach the medical target group during awareness marketing, pharmaceutical companies should mainly address the target group's issues and problems with high-quality content instead of advertising its own products.
- Consideration: During this phase, physicians explore various treatment approaches and methods for a specific medical condition. The goal is to position the company's products as suitable solutions for the indicated condition and related issues. It's essential for pharmaceutical companies to establish their brand as a reliable problem solver that supports physicians in managing the challenges of the disease and its treatment. To achieve this, giving their solution a clear and distinct profile that sets it apart from the competition is crucial. Apart from emphasizing clear competitive advantages such as simpler application or demonstrably superior therapeutic success, the perception of the company among the target group plays a decisive role in shaping this profile. Awareness marketing already plays a significant role in shaping this perception before the consideration phase. Therefore, in this phase, the focus lies on connecting the general brand image with specific products. In market segments where product effects are similar or indistinguishable, effective storytelling can be invaluable in positioning the brand as an innovator, problem solver, or trustworthy partner. The optimal goal is for the brand to establish itself as the "top of mind" – the first association in the target group's mind when faced with a particular problem (e.g., headache -> aspirin).
- Decision: As medical decisions often have significant consequences, building trust plays a pivotal role in finally convincing physicians to try a treatment option. Thus, it's essential for pharmaceutical companies to understand what factors contribute to trust at this stage. For instance, does the physician require specific information, such as study data, or is building a strong interpersonal relationship with the sales force crucial for them? Additionally, a physician's network often plays a decisive role, as they attach great importance to the opinions and experiences of colleagues and medical key opinion leaders (KOLs). Therefore, pharmaceutical companies should not limit their efforts to direct contact with the physician but should also consider their environment when devising their strategy. Personalization of measures becomes increasingly important at this stage. While communication previously occurred at the cohort level, measures in the decision phase become now more tailored to individual physicians.
- Retention: Instead of solely focusing on short-term sales increases, the primary focus of pharmaceutical sales and marketing is to enhance the lifetime value of physicians. Building sustainable customer relationships is essential to leverage the prescription potential of physicians in the long term. The first prescription should be seen as the beginning of a new phase in the customer relationship rather than the endpoint of the customer journey. A physician who has decided to test or prescribe a product presents great potential for sustaining sales growth and promoting further products. Actively nurturing and promoting this relationship is vital. OCM therefore relies continiously enriching customer profiles, with information from each interaction, to develop a detailed understanding of physicians' needs and respond sensitively. This fosters a basis of trust that binds the physician to the company in the long run.
Generally, digital channels play a crucial role in the decision-making process, especially during the early stages. Since most decisions are made by physicians before any direct sales contact, it is imperative for pharmaceutical companies to invest in effective digital marketing early on. As the customer journey progresses, direct contact with the sales force becomes more significant. Furthermore, the focus of communication should align with the respective decision-making phase: the earlier the phase, the less product-heavy the communication should be. As the consideration or decision phase approaches, communication should focus more on the company's specific products. This approach enables pharmaceutical companies to establish a connection with physicians by addressing their current challenges and needs before presenting their products as solutions.
3. Entity of the Customer Journey: Sequences
In OCM marketing, the customer journey faces a delicate balancing act between two conflicting requirements. On one hand, all measures across channels and phases should seamlessly link into an overall flow. On the other hand, it is equally important to continuously adapt contact points based on customer feedback. To address this challenge, the customer journey in OCM is structured into sequences, each representing a series of small stages within the overall journey.
These sequences are typically designed around specific topics or events. For instance, a sequence could revolve around a webinar promoted via LinkedIn, where registrations are collected on the website. Attendees are then kept informed through a newsletter and subsequent email follow-up. Finally, the sales force reaches out to the physician to remind them of the event during a conversation. These actions within the sequence are precisely targeted based on data and previous experiences. This approach enables pharmaceutical companies to develop reliable building blocks for the customer journey, which can be further customized to cater to the unique needs of each target group.
Furthermore, OCM allows for flexible tailoring of each physician's customer journey, depending on their responses, by selecting the appropriate sequence that aligns with their current phase and associated needs. In this regard, pharmaceutical companies stand to gain significant advantages from the wealth of profile data collected for each physician. Leveraging the right data infrastructure , this selection process can even be automated, streamlining internal decision-making processes and providing ample room for data-driven optimization.
By embracing sequences as a fundamental aspect of the customer journey in OCM, pharmaceutical companies can achieve a harmonious blend of cohesion and adaptability. The sequences not only ensure a consistent brand experience but also foster responsive and personalized interactions with physicians at every stage. This strategic approach empowers companies to continually refine and enhance their customer journey, propelling their OCM efforts to new levels of effectiveness and success.
Lead Generation as a Sequence
Lead generation holds a pivotal role within many sequences of OCM marketing. This is because numerous marketing and sales initiatives require the establishment of active contacts, such as opt-ins for newsletters or registrations for events and seminars. The goal of lead generation is to transform passive leads into engaged participants through a three-step process:
- Contact Building: The initial step involves reaching out to leads with topics relevant to their interests. This can be achieved through targeted advertising or content marketing campaigns tailored to keywords and search terms that resonate with the intended audience.
- Conversion: In the second step, these leads are collected at a central point, often a landing page, with the intention of translating their interest into a direct contact. This can entail activities such as registrations, opt-ins, appointment bookings, or content downloads.
- Interaction: The final step leverages the established contact to initiate an exchange with the physician regarding the selected measure, which could involve events, conversations, whitepapers, and more.
The seamless interplay of the three instances - segmentation, decision phases, and sequences - illustrates how customer journeys in OCM effectively combine agility and efficiency. Pharmaceutical companies can actively address the distinct needs and decision-making phases of different physicians, while simultaneously working efficiently by grouping physicians into segments or catering to them individually through automated sequences.
By implementing lead generation as part of a well-designed sequence, pharmaceutical companies can significantly enhance their customer engagement efforts. Effectively capturing and nurturing leads throughout the customer journey ensures a steady stream of informed and receptive prospects. Moreover, this strategic approach allows for more personalized interactions with physicians, leading to a deeper understanding of their unique requirements and facilitating meaningful, long-lasting relationships.
In conclusion, lead generation serves as a vital component in the sequences of OCM marketing. By strategically employing lead generation tactics, pharmaceutical companies can proactively engage with physicians, effectively aligning with their needs and optimizing the overall customer journey experience. This integrated approach contributes to the success of OCM strategies, fostering fruitful collaborations and driving measurable results in the ever-evolving pharmaceutical landscape.
Learn how data management works in Omnichannel Pharma Marketing and how pharma sales and marketing can benefit from it:
✔️ Data processing
✔️ Data infrastructure
✔️ Using data in practice
Learn which channels work in Omnichannel Pharma Marketing and how pharma sales and marketing can benefit from them:
✔️ Push Marketing Channels
✔️ Pull Marketing Channels
✔️ Content Hub